Results 21 to 30 of about 38,316 (201)

Hospitalized patients received furosemide undergoing acute kidney injury: the risk and prediction tool

open access: yesEuropean Journal of Medical Research, 2023
Purpose Furosemide, a frequently prescribed diuretic for managing congestive heart failure and edema, remains a topic of debate regarding its potential risk of inducing acute kidney injury (AKI) in patients.
Chen Guan   +12 more
doaj   +1 more source

On some aspects of furosemide routine prescription at acute respiratory distress syndrome at the prehospital stage

open access: yesActa Biomedica Scientifica, 2016
We studied the effect of furosemide application at the pre-hospital stage on survival rate and mortality risk in patients with acute respiratory distress syndrome.
A. V. Dats   +3 more
doaj   +1 more source

Anaphylactic shock with intravenous furosemide: a rare undesired effect

open access: yesMAMC Journal of Medical Sciences, 2020
Furosemide is a potent diuretic, with structural similarity to sulphonamide antibiotics. Its relative safety profile is one of the reasons to account for its widespread use.
Divya Gahlot   +3 more
doaj   +1 more source

Pharmacokinetics of furosemide in thoroughbred horses subjected to supramaximal treadmill exercise with and without controlled access to water

open access: yesBMC Veterinary Research, 2019
Background The primary objective of this study was to assess the disposition of furosemide in Thoroughbred horses treated intravenously with 1 mg/kg of furosemide 4 and 24 h before supramaximal treadmill exercise without and with controlled access to ...
N. F. Villarino   +3 more
doaj   +1 more source

Furosemide in pediatric intensive care: a retrospective cohort analysis

open access: yesFrontiers in Pediatrics
IntroductionFurosemide is the most commonly used medication in pediatric intensive care. Growing data indicates improved hemodynamic stability and efficacy of furosemide infusions compared to intermittent injections, thereby suggesting furosemide ...
Melany Gaetani   +17 more
doaj   +1 more source

Prophylactic furosemide to prevent transfusion-associated circulatory overload: a randomized controlled study in rats

open access: yesScientific Reports, 2022
Transfusion-associated circulatory overload (TACO) is the leading cause of transfusion related morbidity and mortality. The only treatment is empirical use of furosemide. Our aim was to investigate if furosemide can prevent TACO.
Robert B. Klanderman   +12 more
doaj   +1 more source

Furosemide and Ductus Arteriosus Closure in Very-Low-Birth-Weight Preterm Infants: A Comprehensive Retrospective Study

open access: yesChildren
Ductus arteriosus closure may be delayed in preterm infants, and prostaglandin, a vasodilator, can affect ductal patency. Furosemide can increase renal prostaglandin synthesis, so its net effect on patent ductus arteriosus (PDA) is uncertain. Our goal is
Chi-Mei Kuo   +4 more
doaj   +1 more source

Electrochemical Determination of Furosemide Drug at Tranexamic Acid Gold Nanoparticles Modified Glassy Carbon Electrode

open access: yesPakistan Journal of Analytical & Environmental Chemistry, 2021
The reported work discussed the simpler and sensitive strategy for the electrochemical determination of furosemide by employed tranexamic acid derived gold nanoparticles modified glassy carbon electrode (GCE).
Tasawar Ali Chandio   +5 more
doaj   +1 more source

Inhaled furosemide for relief of air hunger versus sense of breathing effort: a randomized controlled trial

open access: yesRespiratory Research, 2018
Background Inhaled furosemide offers a potentially novel treatment for dyspnoea, which may reflect modulation of pulmonary stretch receptor feedback to the brain.
Joanna C. Grogono   +3 more
doaj   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy